A new pathway of nitric oxide cyclic GMP signaling involving S-nitrosoglutathione

被引:173
作者
Mayer, B
Pfeiffer, S
Schrammel, A
Koesling, D
Schmidt, K
Brunner, F
机构
[1] Graz Univ, Inst Pharmakol & Toxikol, A-8010 Graz, Austria
[2] Free Univ Berlin, Inst Pharmakol, D-14195 Berlin, Germany
关键词
D O I
10.1074/jbc.273.6.3264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO), a physiologically important activator of soluble guanylyl cyclase (sGC), is synthesized from L-arginine and O-2 in a reaction catalyzed by NO synthases (NOS), Previous studies with purified NOS failed to detect formation of free NO, presumably due to a fast inactivation of NO by simultaneously produced superoxide (O-2(radical anion)). To characterize the products involved in NOS-induced sGC activation, we measured the formation of cyclic 3',5'-guanosine monophosphate (cGMP) by purified sGC incubated in the absence and presence of GSH (1 mM) with drugs releasing different NO-related species or with purified neuronal NOS. Basal sGC activity was 0.04 +/- 0.01 and 0.19 +/- 0.06 mu mol of cGMP x mg(-1) x min(-1) without and with 1 mM GSH, respectively. The NO donor DEA/NO activated sGC in a GSH-independent manner, Peroxynitrite had no effect in the absence of GSH but significantly stimulated the enzyme in the presence of the thiol (3.45 a 0.60 mu mol of cGMP x mg(-1) x min(-1)). The NO/O-2(radical anion) donor SIN-1 caused only a slight accumulation of cGMP in the absence of GSH but was almost as effective as DEA/NO in the presence of the thiol, The profile of sGC activation by Ca2+/calmodulin-activated NOS resembled that of SIN-1; at a maximally active concentration of 200 ng/0.1 ml, NOS increased sGC activity to 1.22 +/- 0.12 and 8.51 +/- 0.88 mu mol of cGMP x mg(-1) x min(-1) in the absence and presence of GSH, respectively, The product of NOS and GSH was identified as the thionitrite GSNO, which activated sGC through Cu+-catalyzed release of free NO. In contrast to S-nitrosation by peroxynitrite, the novel NO/O-2(radical anion)-triggered pathway was very efficient (25-45% GSNO) and insensitive to CO2. Cu+-specific chelators inhibited bradykinin-induced cGMP release from rat isolated hearts but did not interfere with the direct activation of cardiac sGC, suggesting that thionitrites may occur as intermediates of NO/cGMP signaling in mammalian tissues.
引用
收藏
页码:3264 / 3270
页数:7
相关论文
共 74 条
[61]   A SCHEME FOR THE COLORIMETRIC DETERMINATION OF MICROGRAM AMOUNTS OF THIOLS [J].
SAVILLE, B .
ANALYST, 1958, 83 (993) :670-672
[62]   No center dot NO from NO synthase [J].
Schmidt, HHHW ;
Hofmann, H ;
Schindler, U ;
Shutenko, ZS ;
Cunningham, DD ;
Feelisch, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14492-14497
[63]  
Schrammel A, 1996, MOL PHARMACOL, V50, P1
[64]  
Schultz G., 1984, METHOD ENZYMAT AN, P379
[65]   NITRIC-OXIDE CIRCULATES IN MAMMALIAN PLASMA PRIMARILY AS AN S-NITROSO ADDUCT OF SERUM-ALBUMIN [J].
STAMLER, JS ;
JARAKI, O ;
OSBORNE, J ;
SIMON, DI ;
KEANEY, J ;
VITA, J ;
SINGEL, D ;
VALERI, CR ;
LOSCALZO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7674-7677
[66]   S-NITROSYLATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR CONFERS VASODILATORY AND ANTIPLATELET PROPERTIES ON THE ENZYME [J].
STAMLER, JS ;
SIMON, DI ;
JARAKI, O ;
OSBORNE, JA ;
FRANCIS, S ;
MULLINS, M ;
SINGEL, D ;
LOSCALZO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8087-8091
[67]   BIOCHEMISTRY OF NITRIC-OXIDE AND ITS REDOX-ACTIVATED FORMS [J].
STAMLER, JS ;
SINGEL, DJ ;
LOSCALZO, J .
SCIENCE, 1992, 258 (5090) :1898-1902
[68]   Structure-function aspects in the nitric oxide synthases [J].
Stuehr, DJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :339-359
[69]   ENZYMIC METHOD FOR QUANTITATIVE DETERMINATION OF NANOGRAM AMOUNTS OF TOTAL AND OXIDIZED GLUTATHIONE - APPLICATIONS TO MAMMALIAN BLOOD AND OTHER TISSUES [J].
TIETZE, F .
ANALYTICAL BIOCHEMISTRY, 1969, 27 (03) :502-&
[70]  
VENTURINI CM, 1993, J PHARMACOL EXP THER, V266, P1497